NeurologyLive Friday 5 — December 25, 2020


Take 5 minutes to catch up on NeurologyLive's highlights from the week ending December 25, 2020.

Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.

1: Expert Perspectives: Recent Approvals for Acute Migraine

Expert physicians consider the recent treatment approvals for the management of acute migraine, and how the shift in expectations outcomes has impacted treatment selection.

2: Reflections on the Impact of COVID-19: A Short Expert Series

This specialty series is dedicated to assessing the impact COVID-19 has had on the quality of life of patients with neurological disorders and the clinicians who were forced to adapt during this unique era of medical history.

3: Sleep Deprivation Among Frontline Health Care Workers During COVID-19 Turns Critical

The pandemic's impact stretches across all aspects of life and has particularly concerning effects on the sleep of those working on the frontlines providing care of patients.

4: Insights: Treatment Options for Dravet Syndrome

M. Scott Perry, MD, discusses historically approved therapies for the first-, second-, and third-line treatment of Dravet syndrome.

5: A Team Approach to Asleep Deep Brain Stimulation

Jason M. Schwalb, MD; Ellen L. Air, MD, PhD; Neepa J. Patel, MD; and Julia A. Wall discuss Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care that has helped it become a leading treatment center for Parkinson disease and related movement disorders.

Related Videos
Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MS
David Z. Rose, MD
Shadi Yaghi, MD, associate professor of neurology at Brown University
Matthew B. Harms, MD, MDA Medical Advisor and Care Center Director, Associate Professor of Neurology at Columbia University Irving Medical Center - Eleanor and Lou Gehrig ALS Center.
Ava L. Liberman, MD, medical director of the Stroke Center at Weill Cornell Medicine
© 2024 MJH Life Sciences

All rights reserved.